Commentary / World Jun 28, 2023
Eli Lilly’s new weight-loss drug is even better than Ozempic
When it comes to manipulating the human metabolism, we’re entering entirely new territory with new drugs.
When it comes to manipulating the human metabolism, we’re entering entirely new territory with new drugs.
Women in the future may soon be able to get a series of shots that teach their immune systems how to quash breast cancer before it becomes a problem.
Judges on the U.S. 5th Circuit appeared worryingly comfortable challenging the expertise of FDA scientists.
The U.S. needs better ways of tracking illicit xylazine, a sedative that’s especially dangerous when mixed with fentanyl.
The decade-long Zoonomia project shows that animals have a lot to teach us about our health, disease, and potentially new ideas for medicines.
Promising data could open the door to insurance coverage for expensive new Alzheimer's drugs, bringing them closer to patients.
A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.
Bringing new drugs to market is already expensive and time-consuming. Undercutting the FDA will only make it harder.
Late-stage data on a treatment in development by Karuna Therapeutics for schizophrenia show promise on sharply reducing harsh side effects.
The American Academy of Pediatrics thinks drugs like Wegovy and Mounjaro could help teens with weight loss.